OncoSil Medical LtdASX: OSL

OncoSil approved for Innovation Funding (NUB) in Germany

· Issued by OncoSil Medical Ltd

Filed with ASX · · 3 pages · English

✓ The Institute for the Hospital Remuneration System (InEK) has granted the OncoSil device with a“Positive Status 1”classification; ✓ 25 leading university hospital sites in Germany submitted requests for innovation funding (NUB) for the OncoSil device; ✓ Hospitals which submitted NUB applications can now individually negotiate with Statutory TM Health Insurance providers (“Sickness Funds”) for re

OncoSil Medical Ltd on 6ix

Earlier from OncoSil Medical

Later from OncoSil Medical

All OncoSil Medical news releases